These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26452232)

  • 61. What is so bad about a hemoglobin level of 12 to 13 g/dL for chronic kidney disease patients anyway?
    Besarab A; Frinak S; Yee J
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):131-42. PubMed ID: 19233072
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.
    Rivara MB; Ikizler TA; Ellis CD; Mehrotra R; Himmelfarb J
    BMC Nephrol; 2015 Jun; 16():79. PubMed ID: 26045064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin.
    Avram MM; Blaustein D; Fein PA; Goel N; Chattopadhyay J; Mittman N
    Kidney Int Suppl; 2003 Nov; (87):S6-11. PubMed ID: 14531767
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
    Lacson E; Wang W; Hakim RM; Teng M; Lazarus JM
    Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 67. UK Renal Registry 15th annual report: Chapter 6 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2011: national and centre-specific analyses.
    Rao A; Gilg J; Williams A
    Nephron Clin Pract; 2013; 123 Suppl 1():125-50. PubMed ID: 23774489
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
    Servilla KS; Singh AK; Hunt WC; Harford AM; Miskulin D; Meyer KB; Bedrick EJ; Rohrscheib MR; Tzamaloukas AH; Johnson HK; Zager PG
    Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intercurrent events and comorbid conditions influence hemoglobin level variability in dialysis patients.
    DeFrancisco AL; Macdougall IC; Carrera F; Braun J; Bárány P; Bridges I; Wheeler T; Tran D; Dietrich A
    Clin Nephrol; 2009 Apr; 71(4):397-404. PubMed ID: 19356372
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
    Skali H; Lin J; Pfeffer MA; Chen CY; Cooper ME; McMurray JJ; Nissenson AR; Remuzzi G; Rossert J; Parfrey PS; Scott-Douglas NW; Singh AK; Toto R; Uno H; Ivanovich P
    Am J Kidney Dis; 2013 Feb; 61(2):238-46. PubMed ID: 23159232
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
    Rheault MN; Molony JT; Nevins T; Herzog CA; Chavers BM
    Kidney Int; 2017 Jan; 91(1):177-182. PubMed ID: 27865440
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study.
    Martínez-Castelao A; Cases A; Carballada AT; Iranzo JT; Bronsoms J; Vallès-Prats M; Monserrat DT; Jimenez EM;
    Nefrologia; 2015; 35(2):179-88. PubMed ID: 26300512
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association of hemoglobin and survival in peritoneal dialysis patients.
    Molnar MZ; Mehrotra R; Duong U; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):1973-81. PubMed ID: 21784829
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypomagnesemia and Mortality in Incident Hemodialysis Patients.
    Li L; Streja E; Rhee CM; Mehrotra R; Soohoo M; Brunelli SM; Kovesdy CP; Kalantar-Zadeh K
    Am J Kidney Dis; 2015 Dec; 66(6):1047-55. PubMed ID: 26184377
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study.
    Akizawa T; Makino H; Matsuo S; Watanabe T; Imai E; Nitta K; Ohashi Y; Hishida A;
    Clin Exp Nephrol; 2011 Apr; 15(2):248-57. PubMed ID: 21234785
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study.
    Aapro M; Ludwig H; Bokemeyer C; MacDonald K; Soubeyran P; Turner M; Albrecht T; Abraham I
    Ann Oncol; 2009 Oct; 20(10):1714-21. PubMed ID: 19570966
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis.
    Wetmore JB; Li S; Yan H; Xu H; Peng Y; Sinsakul MV; Liu J; Gilbertson DT
    PLoS One; 2018; 13(9):e0203767. PubMed ID: 30256836
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Factors related to the absence of anemia in hemodialysis patients.
    Verdalles U; Abad S; Vega A; Ruiz Caro C; Ampuero J; Jofre R; Lopez-Gomez JM
    Blood Purif; 2011; 32(1):69-74. PubMed ID: 21346339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Individualized anemia management enhanced by ferric pyrophosphate citrate protocol.
    Chait Y; Nathanson BH; Germain MJ
    Sci Rep; 2022 Nov; 12(1):20122. PubMed ID: 36418453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
    Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
    BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.